| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |